← Back to Clinical Trials
Recruiting NCT06034990

ICU Fluid Utilization Survey in Southeast Asia

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Critical Illness
Sponsor Chulalongkorn University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2024-01-31
Completion 2025-07-31
Interventions
10-min online survey

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia. The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.

Eligibility Criteria

Inclusion Criteria: 1. Specialty must be in Anesthesiology, Surgery, Critical Care Medicine, Pulmonology, Nephrology, Internal Medicine, General Practitioner 2. Practice must be in Southeast Asia hospitals 3. Must work in Surgical ICU, Medical ICU , and/or Mixed ICU Exclusion Criteria: 1.Physicians who worked in cardiac, neurology or pediatric ICUs

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}